Cytotoxic Activity of a Niclosamide–Caffeic Acid Multicomponent Cocrystal in T47D Breast Cancer Cells
Open Access
- 15 September 2025
- journal article
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (9) , 67-72
Abstract
Objective: This study aimed to evaluate the cytotoxic activity of a niclosamide–caffeic acid multicomponent cocrystal against T47D breast cancer cells. Methods: The multicomponent cocrystal was prepared using the solvent-drop grinding method. Cytotoxic activity was assessed using the Microculture Tetrazolium Test (MTT) assay. Results: The results demonstrated that both niclosamide alone and the niclosamide–caffeic acid multicomponent cocrystal exhibited cytotoxic effects against T47D cells, with IC50 values of 2.92 μg/mL and 2.50 μg/mL, respectively. Microplate spectrophotometric analysis confirmed a concentration-dependent decrease in cell viability for both treatments. Notably, the niclosamide–caffeic acid multicomponent cocrystal displayed a more pronounced cytotoxic effect than niclosamide alone. Conclusions: These findings suggest that the formation of niclosamide–caffeic acid multicomponent crystals may enhance anticancer potential and warrant further investigation as a promising therapeutic approach for breast cancer treatment. Keywords: breast cancer, niclosamide, caffeic acid, multicomponent crystal, cytotoxicity, T47D cells, MTT assay.Keywords
This publication has 29 references indexed in Scilit:
- Growing Interest in Pharmaceutical Cocrystals: A Comprehensive Review of Applications and TrendsChemistrySelect, 2025
- Pharmacological advances and therapeutic applications of niclosamide in cancer and other diseasesEuropean Journal of Medicinal Chemistry, 2025
- Pharmaceutical cocrystals: Unlocking the potential of challenging drug candidatesJournal of Drug Delivery Science and Technology, 2024
- A novel cocrystal approach celecoxib with piperine: Simultaneously enhance dissolution rate and compressibilityJournal of Pharmaceutical Sciences, 2024
- Efficient cocrystal coformer screening based on a Machine learning Strategy: A case study for the preparation of imatinib cocrystal with enhanced physicochemical propertiesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2024
- Therapy-induced normal tissue damage promotes breast cancer metastasisiScience, 2023
- Repurposing of niclosamide as a STAT3 inhibitor to enhance the anticancer effect of chemotherapeutic drugs in treating colorectal cancerLife Sciences, 2020
- Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5Advanced Drug Delivery Reviews, 2016
- Multi-targeted therapy of cancer by niclosamide: A new application for an old drugCancer Letters, 2014
- Morphological assessment of apoptosisMethods, 2008